Future studies of the molecular regulatory mechanism of splicing of exon 21, and molecules associated with the exon 21-encoded region, may lead to a more precise understanding of the function of SLC12A2 in the inner ear, as well as of mechanisms underlying hearing loss, and provide insight for future development of drugs to treat hearing loss related to SLC12A2 dysfunction. Here, SLC12A2 is linked to hearing loss disorder.